While insertion and expression of the viral gene, per se did not lead to diabetes (incidence <1%), the induction of an anti-LCMV CD8+-specific CTL response that reacted with the viral expressed transgene effectively and routinely produced T1D (incidence >94%). Here, CD8A is linked to diabetes mellitus.